-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Prometheus Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2022.
- Prometheus Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$39.5M, a 34.6% decline year-over-year.
- Prometheus Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$123M, a 94.1% decline from 2021.
- Prometheus Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$63.5M, a 127% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)